Human CCR4 +CCR6 +Th17 cells suppress autologous CD8 + T cell responses

Journal of Immunology

Volumn 188, Issue 12, 2012, Pages 6055-6062

  Zhao, Fei ^a   Hoechst, Bastian ^b,c   Gamrekelashvili, Jaba ^a,b   Ormandy, Lars A ^b,d   Voigtländer, Torsten ^b   Wedemeyer, Heiner ^b   Ylaya, Kris ^a   Wang, Xin Wei ^a   Hewitt, Stephen M ^a   Manns, Michael P ^b   Korangy, Firouzeh ^a   Greten, Tim F ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR6; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER PATIENT; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELL PROLIFERATION; CELLULAR IMMUNITY; COCULTURE; CYTOKINE RELEASE; CYTOLYSIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNE EVASION; IN VITRO STUDY; LIVER CELL CARCINOMA; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TH17 CELL;

CARCINOMA, HEPATOCELLULAR; CD8-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; COCULTURE TECHNIQUES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; RECEPTORS, CCR4; RECEPTORS, CCR6; T-LYMPHOCYTE SUBSETS; TH17 CELLS; TUMOR ESCAPE;

EID: 84862623887     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102918     Document Type: Article

References (38)

1. Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27: 485-517.
2. Weaver, C. T., R. D. Hatton, P. R. Mangan, and L. E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25: 821-852. (Pubitemid 46697925)
3. Ye, P., F. H. Rodriguez, S. Kanaly, K. L. Stocking, J. Schurr, P. Schwarzenberger, P. Oliver, W. Huang, P. Zhang, J. Zhang, et al. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colonystimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194: 519-527. (Pubitemid 32835046)
4. Zhang, Z., M. Zheng, J. Bindas, P. Schwarzenberger, and J. K. Kolls. 2006. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm. Bowel Dis. 12: 382-388.
5. Martin-Orozco, N., and C. Dong. 2009. The IL-17/IL-23 axis of inflammation in cancer: friend or foe? Curr. Opin. Investig. Drugs 10: 543-549.
6. Wang, L., T. Yi, M. Kortylewski, D. M. Pardoll, D. Zeng, and H. Yu. 2009. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J. Exp. Med. 206: 1457-1464.
7. Kryczek, I., S. Wei, W. Szeliga, L. Vatan, and W. Zou. 2009. Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 114: 357-359.
8. Kryczek, I., M. Banerjee, P. Cheng, L. Vatan, W. Szeliga, S. Wei, E. Huang, E. Finlayson, D. Simeone, T. H. Welling, et al. 2009. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114: 1141-1149.
9. Miyahara, Y., K. Odunsi, W. Chen, G. Peng, J. Matsuzaki, and R. F. Wang. 2008. Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc. Natl. Acad. Sci. USA 105: 15505-15510.
10. Zhang, J. P., J. Yan, J. Xu, X. H. Pang, M. S. Chen, L. Li, C. Wu, S. P. Li, and L. Zheng. 2009. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J. Hepatol. 50: 980-989.
11. Zhang, B., G. Rong, H.Wei, M. Zhang, J. Bi, L. Ma, X. Xue, G.Wei, X. Liu, and G. Fang. 2008. The prevalence of Th17 cells in patients with gastric cancer. Biochem. Biophys. Res. Commun. 374: 533-537.
12. Lowes, M. A., T. Kikuchi, J. Fuentes-Duculan, I. Cardinale, L. C. Zaba, A. S. Haider, E. P. Bowman, and J. G. Krueger. 2008. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J. Invest. Dermatol. 128: 1207-1211. (Pubitemid 351543220)
13. Barczyk, A., W. Pierzchala, and E. Sozañska. 2003. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir. Med. 97: 726-733. (Pubitemid 36675678)
14. Kirkham, B.W., M. N. Lassere, J. P. Edmonds, K.M. Juhasz, P. A. Bird, C. S. Lee, R. Shnier, and I. J. Portek. 2006. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum. 54: 1122-1131. (Pubitemid 43672925)
15. Duerr, R. H., K. D. Taylor, S. R. Brant, J. D. Rioux, M. S. Silverberg, M. J. Daly, A. H. Steinhart, C. Abraham, M. Regueiro, A. Griffiths, et al. 2006. A genomewide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-1463. (Pubitemid 44871953)
16. El-Serag, H. B. 2011. Hepatocellular carcinoma. N. Engl. J. Med. 365: 1118-1127.
17. Greten, T. F., F. Papendorf, J. S. Bleck, T. Kirchhoff, T. Wohlberedt, S. Kubicka, J. Klempnauer, M. Galanski, and M. P. Manns. 2005. Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br. J. Cancer 92: 1862-1868. (Pubitemid 40826134)
18. Greten, T. F., M. P. Manns, and F. Korangy. 2006. Immunotherapy of hepatocellular carcinoma. J. Hepatol. 45: 868-878. (Pubitemid 44646691)
19. Korangy, F., B. Höchst, M. P. Manns, and T. F. Greten. 2010. Immunotherapy of hepatocellular carcinoma. Expert Rev. Gastroenterol. Hepatol. 4: 345-353.
20. Obermann, S., S. Petrykowska, M. P. Manns, F. Korangy, and T. F. Greten. 2007. Peptide-beta2-microglobulin-major histocompatibility complex expressing cells are potent antigen-presenting cells that can generate specific T cells. Immunology 122: 90-97. (Pubitemid 47222599)
21. Cosmi, L., R. De Palma, V. Santarlasci, L. Maggi, M. Capone, F. Frosali, G. Rodolico, V. Querci, G. Abbate, R. Angeli, et al. 2008. Human interleukin 17- producing cells originate from a CD161+CD4+ T cell precursor. J. Exp. Med. 205: 1903-1916.
22. Kleinschek, M. A., K. Boniface, S. Sadekova, J. Grein, E. E. Murphy, S. P. Turner, L. Raskin, B. Desai, W. A. Faubion, R. deWaal Malefyt, et al. 2009. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J. Exp. Med. 206: 525-534.
23. Acosta-Rodriguez, E. V., L. Rivino, J. Geginat, D. Jarrossay, M. Gattorno, A. Lanzavecchia, F. Sallusto, and G. Napolitani. 2007. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8: 639-646. (Pubitemid 46785128)
24. Allan, S. E., S. Q. Crome, N. K. Crellin, L. Passerini, T. S. Steiner, R. Bacchetta, M. G. Roncarolo, and M. K. Levings. 2007. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19: 345-354. (Pubitemid 46523383)
25. Hoechst, B., J. Gamrekelashvili, M. P. Manns, T. F. Greten, and F. Korangy. 2011. Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. Blood 117: 6532-6541.
26. Budhu, A., M. Forgues, Q. H. Ye, H. L. Jia, P. He, K. A. Zanetti, U. S. Kammula, Y. Chen, L. X. Qin, Z. Y. Tang, and X. W. Wang. 2006. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 10: 99-111. (Pubitemid 44202603)
27. Kuang, D. M., Q. Zhao, Y. Wu, C. Peng, J. Wang, Z. Xu, X. Y. Yin, and L. Zheng. 2011. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J. Hepatol. 54: 948-955.
28. Kryczek, I., S. Wei, L. Zou, S. Altuwaijri, W. Szeliga, J. Kolls, A. Chang, and W. Zou. 2007. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J. Immunol. 178: 6730-6733. (Pubitemid 46847396)
29. Muranski, P., A. Boni, P. A. Antony, L. Cassard, K. R. Irvine, A. Kaiser, C. M. Paulos, D. C. Palmer, C. E. Touloukian, K. Ptak, et al. 2008. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112: 362-373.
30. Benchetrit, F., A. Ciree, V. Vives, G. Warnier, A. Gey, C. Sautès-Fridman, F. Fossiez, N. Haicheur, W. H. Fridman, and E. Tartour. 2002. Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood 99: 2114-2121. (Pubitemid 34525496)
31. Hinrichs, C. S., A. Kaiser, C. M. Paulos, L. Cassard, L. Sanchez-Perez, B. Heemskerk, C. Wrzesinski, Z. A. Borman, P. Muranski, and N. P. Restifo. 2009. Type 17 CD8+ T cells display enhanced antitumor immunity. Blood 114: 596-599.
32. Numasaki, M., M. Watanabe, T. Suzuki, H. Takahashi, A. Nakamura, F. McAllister, T. Hishinuma, J. Goto, M. T. Lotze, J. K. Kolls, and H. Sasaki. 2005. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J. Immunol. 175: 6177-6189. (Pubitemid 41508106)
33. Muranski, P., and N. P. Restifo. 2009. Does IL-17 promote tumor growth? Blood 114: 231-232.
34. Annunziato, F., L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzinghi, E. Parente, L. Filì, S. Ferri, F. Frosali, et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204: 1849-1861. (Pubitemid 47240944)
35. Sallusto, F., and A. Lanzavecchia. 2009. Human Th17 cells in infection and autoimmunity. Microbes Infect. 11: 620-624.
36. Hou, W., H. S. Kang, and B. S. Kim. 2009. Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J. Exp. Med. 206: 313-328.
37. Ahmadzadeh, M., and S. A. Rosenberg. 2005. TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells. J. Immunol. 174: 5215-5223. (Pubitemid 40593159)
38. Chen, M. L., M. J. Pittet, L. Gorelik, R. A. Flavell, R. Weissleder, H. von Boehmer, and K. Khazaie. 2005. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc. Natl. Acad. Sci. USA 102: 419-424. (Pubitemid 40116782)